Brought to you by the Section of Clinical Specialists and Scientists, this featurette from the 2021 Midyear Clinical Meeting will review the role biomarkers play in severe asthma when selecting pharmacotherapy and how to assess the place for non-biologic add on agents in severe asthma therapy.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.